The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment

Vasa - Journal of Vascular Diseases

Volumn 38, Issue 3, 2009, Pages 238-244

  Vitovec, Miroslav ^a   Golan L ^a   Roztocil K ^a   Linhart, A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Deep venous thrombosis; Duplex ultrasound

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FEMORAL VEIN; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPLITEAL VEIN; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT RESPONSE; TREND STUDY; AGED; BLOOD; BLOOD CLOTTING; DOPPLER ECHOGRAPHY; DRUG ADMINISTRATION; DRUG EFFECT; HOSPITALIZATION; MIDDLE AGED; TIME; TREATMENT OUTCOME; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMORAL VEIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POPLITEAL VEIN; RECURRENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS; WARFARIN;

EID: 73149099629     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.38.3.238     Document Type: Article

References (26)

1. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl): 401S-428S.
2. Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost. 2002; 88(3): 402-406.
3. Linkins LA, Pasquale P, Paterson S, Kearon C. Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis. Arch Intern Med. 2004; 164(16): 1793-1796.
4. Jimenez D, Diaz G, Marin E, Vidal R, Sueiro A, Yusen RD. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Thromb Haemost. 2006; 95(3): 562-566.
5. van Ramshorst B, van Bemmelen PS, Hoeneveld H, Faber JA, Eikelboom BC. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation. 1992; 86(2): 414-419.
6. Savory L, Harper P, Ockelford P. Posttreatment ultrasound-detected residual venous thrombosis: a risk factor for recurrent venous thromboembolism and mortality. Curr Opin Pulm Med. 2007; 13(5): 403-408.
7. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton Iii LJ. Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Cohort Study. Vol 160; 2000: 761-768.
8. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, Frulla M, Mosena L, Tormene D, Piccioli A, Simioni P, Girolami A. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002; 137(12): 955-960.
9. Prandoni P, Lensing AWA, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome: A Randomized, Controlled Trial. Vol 141; 2004: 249-256.
10. Ginsberg JS, Hirsh J, Julian J, Vander LaandeVries M, Magier D, MacKinnon B, Gent M. Prevention and Treatment of Postphlebitic Syndrome: Results of a 3-Part Study. Vol 161; 2001: 2105-2109.
11. Brandjes DP BH, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997; 15(349): 759-762.
12. Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of lowdose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med. 2007; 147(8): 525-533.
13. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P, for the Warfarin Optimal Duration Italian Trial I. Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism. Vol 139; 2003: 19-25.
14. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA, Johnston M, Douketis J, Roberts R, van Nguyen P, Kassis J, Dolan S, Demers C, Desjardins L, Solymoss S, Trowbridge A. A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism. Vol 340; 1999: 901-907.
15. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001; 345(3): 165-169.
16. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ, the PI. Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism. Vol 348; 2003: 1425-1434.
17. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B,Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M, the Extended Low-Intensity Anticoagulation for Thrombo-Embolism I. Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism. Vol 349; 2003: 631-639.
18. Krupski WC, Bass A, Dilley RB, Bernstein EF, Otis SM. Propagation of deep venous thrombosis identified by duplex ultrasonography. J Vasc Surg. 1990; 12(4): 467-474; discussion 474-465.
19. Vítovec M, Roztocil K , FrídlP. Thrombus regresion after six month standard therapy versus extended anticoagulation for one year. A duplex scanning imaging study. Minerva Cardiologica. 2000; 48(9): 202.
20. Lobo JL, Jimenez D, Teresa Orue M, Grau E, Naufall D, Madridano O, Monreal M. Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism. Br J Haematol. 2007; 138(3): 400-403.
21. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995;332(25):1661-1665.
22. Kearon C. Drug trials that have influenced our practice in the treatment of venous thromboembolism. Thromb Haemost. 1997;78(1):553-557.
23. Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE. Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med. 2007;357(11):1105-1112.
24. Kearon C, Kovacs MJ, Julian JA. Deep vein thrombosis. Lancet. 2005;366(9480):118; author reply 119-120.
25. Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Larfars G, Leijd B, Linder O, Loogna E. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med. 1997;336(6):393-398.
26. Oghi S, Ito K, Tanaka K. Echogenic types of venous thrombi in the common femoral vein by ultrasonic B-mode imaging.Vasurgeryscular 1991;25:253-258.